Inactive Instrument

Imaging3, Inc. Stock OTC Bulletin Board

Equities

US45248F1030

Medical Equipment, Supplies & Distribution

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Imaging3, Inc.
Sales 2020 3.67M Sales 2021 589K Capitalization 10.59M
Net income 2020 -4M Net income 2021 -5M EV / Sales 2020 13 x
Net Debt 2020 4.74M Net Debt 2021 5.62M EV / Sales 2021 27.5 x
P/E ratio 2020
-8.5 x
P/E ratio 2021
-1.78 x
Employees -
Yield 2020 *
-
Yield 2021
-
Free-Float 63.55%
More Fundamentals * Assessed data
Grapefruit USA, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Hall of Fame Wrestler and Cannabis Pioneer Rob Van Dam to Launch RVD Cannabis Brand in California Through Licensing Deal with Grapefruit USA, Inc CI
Grapefruit USA, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Grapefruit USA, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
California Department of Cannabis Control Renews Grapefruit USA's California Cannabis Distributor License by May 13, 2023 CI
Health Canada Approves NNCP for Grapefruit USA, Inc. Hourglass Time Release THC+CBD Delivery Cream CI
Grapefruit USA, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Grapefruit USA, Inc. Auditor Raises 'Going Concern' Doubt CI
Grapefruit’S Summit Boys Brand Goes Mobile on Blitzdirect.com CI
Grapefruit USA, Inc. signed a Memorandum of Understanding to acquire Substantially All Assets of Diagnostic Lab Corporation, Inc. from Diagnostic Lab Corporation, Inc. CI
Grapefruit USA, Inc. Updates on Hourglass Health Canada NNCP Submission CI
Grapefruit Usa, Inc. Announces CEO Bradley J. Yourist Has Been Elected to the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park’S Property Owners Association Board of Directors CI
Grapefruit USA Announce Official Launch of Patented Time-Release, Hemp-Based CBD Topical Cream with Boosted Bioavailability, Made Possible by Its Proprietary Hourglass? Technology CI
Grapefruit USA, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Grapefruit USA Announces Expanded Agreement with Canadian Firms Medz Cannabis and 6PAK Solutions to Shepherd Grapefruit’s Patented Hourglass™ Time Release THC+CBD Delivery Cream Through Health Canada’s Regulatory Process CI
More news
Managers TitleAgeSince
Chief Executive Officer 54 -
Director of Finance/CFO 68 18-02-28
Chief Operating Officer 54 -
Members of the board TitleAgeSince
Chief Executive Officer 54 -
Chief Operating Officer 54 -
Director/Board Member - 20-01-21
More insiders
Grapefruit USA, Inc. is a fully licensed cannabiotech company. The Company manufactures its product line and distribute it, along with other cannabis products, to all licensed cannabis product businesses. It owns an ethanol extraction facility in the City of Desert Hot Springs, California. It owns and operates a Type 6 Ethanol Extraction Plant which removes the essential cannabis compounds, such as THC Distillate, that the Company, and others use, to produce cannabis products. Grapefruit manufactures its Hourglass Time Release THC+CBD-Infused Topical Cream at its Coachillin' facility. Hourglass is the full spectrum THC+ Cannabinoid Topical delivery Cream that provides its users with a full body, synergistic entourage. Its Topical Cream is designed to deliver the full effects of THC combined with a range of cannabinoids for a user's overall health, wellness, and well-being. In addition, its extraction lab produces distillate or Honey Oil from cannabis trim sourced by Grapefruit.
More about the company